Mail

UK markets close in 5 hours 27 minutes

FTSE 100
7,536.40
+52.15(+0.70%)
FTSE 250
18,552.93
+156.24(+0.85%)
AIM
795.20
+2.75(+0.35%)
GBP/EUR
1.1370
-0.0004(-0.04%)
GBP/USD
1.2347
+0.0010(+0.08%)
Bitcoin GBP
22,936.28
+1,165.17(+5.35%)

How much money do you need for a comfortable retirement

And how to build a healthy-sized pension pot

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.0600

-0.0400

(-3.64%)

At close: 04:00PM EDT

1.0800

+0.02

(+1.89%)

Pre-market:

05:33AM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	N/A
Enterprise value	N/A
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	11.23
Price/book (mrq)	1.33
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	2.32
52-week change ³	-60.74%
S&P500 52-week change ³	-13.71%
52-week high ³	4.3500
52-week low ³	1.0500
50-day moving average ³	1.4812
200-day moving average ³	1.9096

Share statistics

Avg vol (3-month) ³	6.4M
Avg vol (10-day) ³	4.45M
Shares outstanding ⁵	306.24M
Implied shares outstanding ⁶	N/A
Float ⁸	300.58M
% held by insiders ¹	1.82%
% held by institutions ¹	27.82%
Shares short (14 Mar 2023) ⁴	54.78M
Short ratio (14 Mar 2023) ⁴	7.94
Short % of float (14 Mar 2023) ⁴	17.90%
Short % of shares outstanding (14 Mar 2023) ⁴	17.89%
Shares short (prior month 14 Feb 2023) ⁴	49.2M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2022
Most-recent quarter (mrq)	30 Dec 2022

Profitability

Profit margin	0.00%
Operating margin (ttm)	-466.09%

Management effectiveness

Return on assets (ttm)	-23.66%
Return on equity (ttm)	-45.21%

Income statement

Revenue (ttm)	27.8M
Revenue per share (ttm)	0.10
Quarterly revenue growth (yoy)	30.40%
Gross profit (ttm)	5.95M
EBITDA	-119.96M
Net income avi to common (ttm)	-132.6M
Diluted EPS (ttm)	-0.4600
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	113.19M
Total cash per share (mrq)	0.37
Total debt (mrq)	11.67M
Total debt/equity (mrq)	4.68
Current ratio (mrq)	4.38
Book value per share (mrq)	0.84

Cash flow statement

Operating cash flow (ttm)	-124.82M
Levered free cash flow (ttm)	-61.27M